Endothelial Growth Factors

"Endothelial Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.

Descriptor ID	D016228
MeSH Number(s)	D12.644.276.390 D12.776.467.390 D23.529.390
Concept/Terms	Endothelial Growth Factors Endothelial Growth Factors Growth Factors, Endothelial Endo-GF Endothelial Growth Factor Polypeptides Endothelial Growth Factor Growth Factor, Endothelial ECDGF Endothelial Cell-Derived Growth Factors Endothelial Cell Derived Growth Factors beta-Endothelial Growth Factor beta-Endothelial Growth Factor Growth Factor, beta-Endothelial beta Endothelial Growth Factor alpha-Endothelial Growth Factor alpha-Endothelial Growth Factor Growth Factor, alpha-Endothelial alpha Endothelial Growth Factor

Below are MeSH descriptors whose meaning is more general than "Endothelial Growth Factors".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Intercellular Signaling Peptides and Proteins [D12.644.276]
Endothelial Growth Factors [D12.644.276.390]
Proteins [D12.776]
Intercellular Signaling Peptides and Proteins [D12.776.467]
Endothelial Growth Factors [D12.776.467.390]
Biological Factors [D23]
Intercellular Signaling Peptides and Proteins [D23.529]
Endothelial Growth Factors [D23.529.390]

Below are MeSH descriptors whose meaning is more specific than "Endothelial Growth Factors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Endothelial Growth Factors" by people in this website by year, and whether "Endothelial Growth Factors" was a major or minor topic of these publications.

Bar chart showing 17 publications over 8 distinct years, with a maximum of 5 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1999	1	0	1
2000	1	1	2
2001	1	0	1
2002	0	3	3
2003	0	2	2
2021	0	2	2
2022	1	4	5

Below are the most recent publications written about "Endothelial Growth Factors" by people in Profiles.

Patel SN. Pulmonary Hypertension and Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity-Is There a Link? JAMA Ophthalmol. 2022 11 01; 140(11):1094-1095.

View in: PubMed
Salabati M, Mahmoudzadeh R, Starr MR, Zhang Q, Sharpe J, Hsu J, Ho AC, Regillo C, Kuriyan AE. REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial. Retina. 2022 11 01; 42(11):2059-2065.

View in: PubMed
Bui YT, Starr MR, Kung FF, Mejia CA, Bakri SJ. Long-Term Visual Outcomes in Exudative Age-Related Macular Degeneration Patients With Unanticipated Gaps in Therapy. Ophthalmic Surg Lasers Imaging Retina. 2022 09; 53(9):481-489.

View in: PubMed
Shah SM, Boopathiraj N, Starr MR, Dalvin LA, AbouChehade J, Damento G, Garcia MD, Hodge DO, Bakri SJ, Sit AJ, Iezzi R. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2022 11; 243:98-108.

View in: PubMed
Sarohia GS, Nanji K, Khan M, Khalid MF, Rosenberg D, Deonarain DM, Phillips MR, Thabane L, Kaiser PK, Garg SJ, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes. Surv Ophthalmol. 2022 Sep-Oct; 67(5):1346-1363.

View in: PubMed
Nanji K, Khan M, Khalid MF, Xie JS, Sarohia GS, Phillips M, Thabane L, Garg SJ, Kaiser P, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis. Acta Ophthalmol. 2022 Sep; 100(6):e1199-e1208.

View in: PubMed
Salabati M, Mahmoudzadeh R, Wong JC, Patel D, Patel SN, Obeid A, Sivalingam A, Vander JF, Garg SJ, Ho AC, Regillo CD, Hsu J. Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy. Br J Ophthalmol. 2022 12; 106(12):1742-1747.

View in: PubMed
Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 2003 Jun; 130(12):2779-91.

View in: PubMed
Sansing LH, Kaznatcheeva EA, Perkins CJ, Komaroff E, Gutman FB, Newman GC. Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment. J Neurosurg. 2003 May; 98(5):985-92.

View in: PubMed
Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene. 2002 Jul 18; 21(31):4765-77.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement